| scholarly article | Q13442814 |
| P2093 | author name string | Soloway MS | |
| Ishikawa S | |||
| Todd B | |||
| van der Zwaag R | |||
| P433 | issue | 5 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 53-56 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Prognostic factors in patients with advanced prostate cancer. | |
| P478 | volume | 33 |
| Q36015058 | Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer |
| Q37502039 | Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study |
| Q24658301 | Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer |
| Q44367943 | Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer |
| Q33607710 | Hormonal therapy for stage D cancer of the prostate |
| Q31833393 | Intracranial metastasis in prostatic cancer |
| Q44124134 | Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival |
| Q52041722 | Metastatic prostatic adenocarcinoma presenting as a pituitary mass: shrinkage of the lesion and clinical improvement with medical treatment. |
| Q43631411 | Modified method of radical retropubic prostatectomy for localized prostatic cancer |
| Q44187033 | Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer |
| Q63243969 | Palliative treatment of bone metastases with samarium-153 EDTMP at onset of pain |
| Q46523330 | Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancer |
| Q35211257 | Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT). |
| Q54662687 | Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer. |
| Q41054535 | The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model |
Search more.